💊 Médicaments A-Z 🧬 Cibles 🛠 Outils 📚 Guides
Tous les médicaments Classes de médicaments Aires thérapeutiques Effets Indésirables
Guides Glossaire Chronologie
Comparaisons Parcours des médicaments Familles de médicaments
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Carvedilol Phosphate

CHEMBL1201167 Phase 4 Approuvé Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
1027.0 g/mol
LogP
—
Phase
4

The phosphate salt form of carvedilol shares the same nonselective beta and alpha-1 adrenergic blocking properties as the parent drug, used in treating heart failure and hypertension. The extended-release phosphate formulation allows for once-daily dosing, which may improve patient adherence. It carries the same monitoring requirements as carvedilol, including for bradycardia and hypotension.

Masse moléculaire

1027,0000 g/mol

TPSA

308,00 Ų

Aires thérapeutiques

Hypertension Breast Cancer Heart Failure

Mécanisme d'action

Non-selective beta-blocker with alpha-1 blocking activity.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Non-selective beta-blocker with alpha-1 blocking activity.

Structure 2D

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O=P(O)(O)O

                

                

                
                

                    
InChI

                    
InChI=1S/C24H26N2O4.H3O4P/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20;1-5(2,3)4/h2-12,17,25-27H,13-16H2,1H3;(H3,1,2,3,4)

                

                

                

                    
                    

                        
Molecular Formula

                        
C48H60N4O17P2

                    

                    
                    

                        
HBD / HBA

                        
13 / 19

                    

                    
                    

                        
Liaisons Rotatives

                        
20

                    

                    
                    
                    

                        
Atomes Lourds

                        
71

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
Foire aux questions

                

                    
                    

                        
                        

                            
The phosphate salt form of carvedilol shares the same nonselective beta and alpha-1 adrenergic blocking properties as the parent drug, used in treating heart failure and hypertension. The extended-release phosphate formulation allows for once-daily dosing, which may improve patient adherence. It carries the same monitoring requirements as carvedilol, including for bradycardia and hypotension.

                        

                    

                    

                    

                    
                    

                        
                        

                            
Non-selective beta-blocker with alpha-1 blocking activity.

                        

                    

                    

                    

                    

                        
                        

                            
Yes, Carvedilol Phosphate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

                        

                    

                

            

            

            
            

            
            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL1201167.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 11954344.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.




        


        
        
    


    



    
Avertissement médical

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.